Skip to content

To ensure that new discoveries deliver patient benefits, we work with industry partners through commercial partnerships, industry-sponsored research and university spin-out companies. We have expertise in navigating regulatory pathways, particularly the introduction of new areas of technology and in clinical trials.

We have a number of highly-productive relationships with small and large companies, particularly in the areas of diagnostic development, vaccines, and clinical trials.

The institute has an impressive record of generating spin-out companies, creating commercial development opportunities for our research, ranging from fundamental scientific discoveries to close-to-clinic applications. 


Find a profileSearch by A-Z